| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 09/26/2002 | WO2002060382A3 Novel compounds and uses thereof |
| 09/26/2002 | WO2002049752A3 Multi-step method for producing gas-filled microcapsules |
| 09/26/2002 | WO2001095711A3 Transgenic mice containing nuclear hormone receptor gene disruptions |
| 09/26/2002 | WO2001015744A9 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| 09/26/2002 | WO2000078228A9 Absorbable sponge with contrasting agent |
| 09/26/2002 | US20020138862 Mice show an increased insulin sensitivity, and resistance to weight gain compared to wild-type mice on same diet; screening for enzyme inhibitors; antiobesity, antidiabetic agents |
| 09/26/2002 | US20020138861 Mice models of human prostate cancer progression |
| 09/26/2002 | US20020138856 Rat selectively bred to be more depressed, as defined by a forced swim test immobility score; screening for antidepressants, genes responsible for depression |
| 09/26/2002 | US20020137965 By para-hydrogen or ortho-deuterium induced nuclear spin polarization of an unsaturated compound; contrast agent for a magnetic resonance (MR) imaging |
| 09/26/2002 | US20020137803 Composition and method for delivering active agents |
| 09/26/2002 | US20020137127 Culture product; polypeptides |
| 09/26/2002 | US20020137122 Ligand-specific opening of a gated-porin channel in the outer membrane of living bacteria |
| 09/26/2002 | US20020137109 Anticarcinogenic agents;monitoring therapy efficiency |
| 09/26/2002 | US20020136760 Carboxylated phosphatidic acid esters |
| 09/26/2002 | US20020136726 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 09/26/2002 | US20020136719 For biomedical applications, including biological delivery to humans and animals |
| 09/26/2002 | US20020136694 Fluid medium for passage through lumen of catheter or other medical device, comprising biocompatible surfactant |
| 09/26/2002 | US20020136693 Magnetic particles for diagnostic purposes |
| 09/26/2002 | US20020136692 Contrast enhancement agent for magnetic resonance imaging |
| 09/26/2002 | US20020136691 Pharmacological evaluation test (PET) in animals for continuous assessment of physiological functions |
| 09/26/2002 | US20020136688 Methods for treating AVM's using radioactive compositions |
| 09/26/2002 | CA2771039A1 Device and method for the photodynamic diagnosis of tumor tissue |
| 09/26/2002 | CA2441673A1 Light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 09/26/2002 | CA2441111A1 Method for targeting chemical compounds to cells and pharmaceutical compositions used therein |
| 09/25/2002 | EP1242125A2 Microparticles based on aspartic acid and use thereof as mri contrast agents |
| 09/25/2002 | EP1241986A1 Use of poly-nitroxyl-functionalized dendrimers as contrast enhancing agents in mri imaging of joints |
| 09/25/2002 | EP0975580B1 Contrast agent preparation |
| 09/25/2002 | EP0804251B1 Blood-pool imaging compositions use and method |
| 09/25/2002 | CN1371405A Radio-opaque molded plastic parts |
| 09/25/2002 | CN1371290A Rhodamine diagnostic agent and diagnostic method for detection of epithelial cancer |
| 09/24/2002 | US6455668 Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
| 09/24/2002 | US6455267 Methods and kits useful for determining the status of and detecting pancreatic B-cell associated autoimmune diseases |
| 09/24/2002 | US6455044 5c8 antigen |
| 09/24/2002 | US6455027 Methods and kits for identifying ductal orifices in a nipple |
| 09/24/2002 | US6455025 Polysaccharide-peptide derivatives |
| 09/24/2002 | US6454738 Methods for delivering in vivo uniform dispersed embolic compositions of high viscosity |
| 09/19/2002 | WO2002072830A2 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | WO2002072794A2 Immunoglobulin superfamily proteins |
| 09/19/2002 | WO2002072636A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 09/19/2002 | WO2002072630A2 Nucleic acid-associated proteins |
| 09/19/2002 | WO2002072551A2 A non-traumatic model for neurogenic pain |
| 09/19/2002 | WO2002072155A2 Use of sydnonimines for specific diagnoses of erectile dysfunctions |
| 09/19/2002 | WO2002072154A1 Paramagnetic nanoparticle |
| 09/19/2002 | WO2002072153A1 Agents for measuring pyrimidine metabolizability |
| 09/19/2002 | WO2002071994A1 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 09/19/2002 | WO2002071950A1 Patch for screening the sensitivity state of a subject with respect to an allergen and use thereof |
| 09/19/2002 | WO2002024695A3 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
| 09/19/2002 | WO2002010192A3 Somatostatin analogues |
| 09/19/2002 | US20020133833 Methods of assessing the effect of a gene of interest on human prostate cancer progression |
| 09/19/2002 | US20020133629 Encapsulating fibre channel signals for transmission over non-fibre channel networks |
| 09/19/2002 | US20020133019 Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and vivo imaging and prevention of amyloid deposition |
| 09/19/2002 | US20020132845 Compositions and methods for the prevention and treatment of tissue ischemia |
| 09/19/2002 | US20020132318 Preferential polypeptide for use as tools in the diagnosis, classification and treatment of tumors |
| 09/19/2002 | US20020132283 Composition for monitoring the metabolism of pyrimidines |
| 09/19/2002 | US20020131966 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs |
| 09/19/2002 | US20020131936 Assessment of concentration of inhalational compounds in the brain |
| 09/19/2002 | CA2441495A1 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | CA2440618A1 Immunoglobulin superfamily proteins |
| 09/19/2002 | CA2439925A1 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 09/19/2002 | CA2437756A1 Nucleic acid-associated proteins |
| 09/19/2002 | CA2433353A1 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 09/18/2002 | EP1239886A2 Labelled ascorbic acid derivatives |
| 09/18/2002 | EP1239874A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 09/18/2002 | EP0981748A4 Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
| 09/18/2002 | EP0901460B1 A process for the preparation of 5-amino-2,4,6-triiodo-1,3-benzenedicarboxylic acid derivatives |
| 09/18/2002 | EP0769969B1 Gas-filled microspheres with fluorine-containing shells |
| 09/18/2002 | CN1370161A Novel quaternary ammonium compounds, its prepn. methods and medicinal application |
| 09/18/2002 | CN1370071A Drug for treating fractures |
| 09/18/2002 | CN1369311A Ultrasonic contrast medium and its preparing process |
| 09/18/2002 | CN1091057C Sol-gel coated polarization vessels |
| 09/17/2002 | US6452065 Transgenic mouse expressing non-native wild-type and familial Alzheimer's Disease mutant presenilin 1 protein on native presenilin 1 null background |
| 09/17/2002 | US6451980 Antibody testing; obtain sample, incubate with binding particles, detect signal |
| 09/17/2002 | US6451543 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 09/17/2002 | US6451312 Diagnosis, imaging; induction of endothelial cell surface antigens |
| 09/17/2002 | US6451310 Preventing t cell activation of b cells by administering antibody cabable of binding protein recognized by monoclonal antibody 5c8 |
| 09/17/2002 | CA2042974C Use of a 1-(2-naphthylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for the manufacture of a medicament for the treatment of cerebral and neuronal diseases |
| 09/12/2002 | WO2002070678A2 Regulation of human serine/threonine protein kinase |
| 09/12/2002 | WO2002069930A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | WO2002069908A2 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 09/12/2002 | WO2002032375A8 Uses of monoclonal antibody 8h9 |
| 09/12/2002 | WO2002014369A3 Human kininogen d5 domain polypeptides and their use |
| 09/12/2002 | WO2002013796A3 Use of proton pump inhibitors for treating diseases of the locomotor system |
| 09/12/2002 | WO2001040519A3 Methods for identifying modulators for balance related disorders |
| 09/12/2002 | WO2001040232A9 Chlorophyll and bacteriochlorophyll esters, and their preparation |
| 09/12/2002 | WO2001036510A3 Use of poly(diallylamine) polymers |
| 09/12/2002 | WO2000067792A9 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 09/12/2002 | US20020129392 Immunocompetent animals including xenogeneic implants of mesenchymal stem cells |
| 09/12/2002 | US20020129391 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 09/12/2002 | US20020129390 Methods of assessing the effect of a gene of interest on human prostate cancer progression |
| 09/12/2002 | US20020129388 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of atherosclerosis |
| 09/12/2002 | US20020128472 N-(6-hydroxy-2,2-dimethyl-1,3-dioxepan-5-yl)-1,4,7,10 -tetraazacyclododecane or its complex reacted with lithium chlroide or lithium bromide with chloro or bromoacetic acid and lithium hydroxide |
| 09/12/2002 | US20020128451 Phthalamide-lanthanide complexes for use as luminescent markers |
| 09/12/2002 | US20020128303 Injection with a photodynamic compound having tumor selective uptake which is activated at a particular light frequency; injection with a xanthenone-4-acetic acid or salt; exposing the tumor to light at the activation frequency |
| 09/12/2002 | US20020128200 Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individuals |
| 09/12/2002 | US20020127634 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 09/12/2002 | US20020127612 Cell proliferation polypeptide for use in the diagnosis and treatment of tumors |
| 09/12/2002 | US20020127573 Diagnosing preferential dermatitis in humans; obtain cells, recover nucleotide sequences, screen for gene coding cytokines, monitor expression of cytokine, amplfied cytokine concentration indicates dermatitis |
| 09/12/2002 | US20020127244 Fractionating a mixture of polyethylene glycol(PEG)-protein adducts comprising partitioning the PEG/protein adducts in a PEG-containing aqueous biphasic system |
| 09/12/2002 | US20020127210 Transplants for myocardial scars |
| 09/12/2002 | US20020127198 Compositions and methods for enhancing drug delivery across and into epithelial tissues |